Skogman Malena E, Kanerva Sonja, Manner Suvi, Vuorela Pia M, Fallarero Adyary
Pharmaceutical Design and Discovery Group (PharmDD), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, FI-00014 Helsinki, Finland.
Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Abo Akademi University, BioCity, Artillerigatan 6 A, FI-20520 Turku, Finland.
Molecules. 2016 Sep 10;21(9):1211. doi: 10.3390/molecules21091211.
Quorum sensing (QS) is the process by which bacteria produce and detect signal molecules to coordinate their collective behavior. This intercellular communication is a relevant target for anti-biofilm therapies. Here we have optimized a screening-applicable assay to search for new quorum sensing inhibitors from natural compound libraries. In this system, QS is correlated with the production of violacein, which is directly controlled by the LuxI/LuxR system in Chromobacterium violaceum ATCC 31532. The parallel use of C. violaceum Tn5-mutant CV026, which depends on auto-inducer addition, allows simultaneous discrimination of compounds that act as quenchers of the AHL signal (quorum quenchers). The incorporation of a redox stain into the platform allowed further distinction between QS inhibitors, quorum quenchers and antibacterial compounds. A pilot screening was performed with 465 natural and synthetic flavonoids. All the most active compounds were flavones and they displayed potencies (IC50) in the range of 3.69 to 23.35 μM. These leads were particularly promising as they inhibited the transition from microcolonies into mature biofilms from Escherichia coli and Pseudomonas aeruginosa strains. This approach can be very effective in identifying new antimicrobials posing lesser risks of resistance.
群体感应(QS)是细菌产生和检测信号分子以协调其群体行为的过程。这种细胞间通讯是抗生物膜疗法的一个相关靶点。在此,我们优化了一种适用于筛选的检测方法,以从天然化合物库中寻找新的群体感应抑制剂。在这个系统中,群体感应与紫色杆菌素的产生相关,而紫色杆菌素由紫色色杆菌ATCC 31532中的LuxI/LuxR系统直接控制。依赖于添加自诱导剂的紫色色杆菌Tn5突变体CV026的平行使用,能够同时区分作为AHL信号淬灭剂(群体淬灭剂)的化合物。在该平台中加入氧化还原染色剂,能够进一步区分群体感应抑制剂、群体淬灭剂和抗菌化合物。对465种天然和合成黄酮类化合物进行了初步筛选。所有活性最强的化合物都是黄酮,它们的效力(IC50)在3.69至23.35 μM范围内。这些先导化合物特别有前景,因为它们抑制了大肠杆菌和铜绿假单胞菌菌株从微菌落向成熟生物膜的转变。这种方法在识别具有较低耐药风险的新型抗菌药物方面可能非常有效。